Penile Traction Therapy by SizeGenetics - UK

Episode SummaryThis episode explains why DIY penis weights and homemade traction rigs are dangerous — not because traction itself is risky, but because the therapeutic window for safe tissue remodeling is narrow and impossible to measure without a calibrated device. We compare DIY methods against the clinical evidence behind FDA-registered penile traction therapy.Key FindingsTherapeutic window: Safe remodeling occurs roughly between 900 and 1500 grams of force — DIY rigs cannot measure thisDocumented DIY injuries: Dorsal nerve damage, tunica micro-tears, acquired curvature, ischemic events, persistent erectile dysfunctionClinical evidence gap: Zero peer-reviewed studies have evaluated hanging weights or homemade rigs as safe protocolsMedical device results: Almsaoud 2023 meta-analysis showed 1.9 cm mean gain using only calibrated devicesSafety profile: FDA-registered devices show only mild, temporary side effects in 11 to 14 percent of users with no serious adverse eventsThe ScienceMechanotransduction — the cellular response to controlled tension — only triggers safe collagen remodeling within a precise force range. Exceed it and tissue tears faster than it heals, leading to scar formation, vascular compromise, and nerve damage.About SizeGeneticsFDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.ResourcesFull Guide: DIY Penis Weights and Traction DangersIs Penile Traction Therapy Safe?Safety Profile and Side EffectsBest Penile Traction DevicesClinical Studies OverviewMedical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

Episode SummaryThis episode examines what clinician-measured before and after data actually shows for penile traction therapy. We review pooled findings from over 1,000 patients across 12 peer-reviewed studies, including a landmark randomized controlled trial.Key FindingsAverage Length Gain: 1.9 cm clinician-measured across 12 pooled studies (Almsaoud 2023 meta-analysis)RCT Evidence: Toussi 2021 reported 1.6 cm in traction group versus 0.3 cm in controls (82 patients)Curvature Correction: 27 percent mean reduction in penile curvature in Peyronie's patientsAdherence: 82 percent compliance rate correlated with stronger outcomesMethodology: Stretched penile length measured from pubic bone to glans tip by cliniciansThe ScienceSustained mechanical tension applied over months encourages cellular proliferation and tissue expansion in the tunica albuginea and corporal structures, producing measurable changes documented under standardized clinical protocols.About SizeGeneticsFDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.ResourcesFull Guide: Before and After Penile Traction TherapyClinical Studies OverviewResults and Length GainsTreatment TimelinePeyronie's Disease TreatmentMedical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

Episode SummaryDoes penile traction therapy actually work? This episode walks through more than 15 peer-reviewed trials, a 2023 meta-analysis, and the biological mechanism behind documented length gains — separating clinical evidence from category hype.Key FindingsMeta-Analysis (Almsaoud 2023): Weighted mean length gain of 1.9 cm across 12 pooled studiesToussi 2021 RCT: 1.6 cm gain in traction group vs. 0.3 cm in controls; 87 percent would repeat therapy, 93 percent would recommendGontero et al.: Mean gain of 1.3 cm; Nikoobakht et al.: 1.7 cm in flaccid and stretched lengthCurvature: 27 percent mean curvature improvement reported in pooled dataProtocol: Typical regimen is 4 to 6 hours daily over 3 to 6 months; 82 percent adherence rateSafety: No serious adverse events reported; mild side effects in roughly 11 to 14 percent of usersThe ScienceMechanotransduction is the cellular response to sustained mechanical force. Calibrated tension applied over time triggers tissue remodeling and true elongation — a structural change, not temporary swelling.About SizeGeneticsFDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.ResourcesFull Guide: Does Penile Traction Therapy Work?Penile Traction Therapy ResultsClinical Studies OverviewHow Penile Traction Therapy WorksTreatment Protocol GuideMedical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

Episode SummaryThis penile traction therapy FAQ episode answers the most common questions men ask about the treatment, drawing on more than 15 peer-reviewed clinical studies and over 1,000 patients. Learn what penile traction therapy is, how it works, who it's for, and what the clinical evidence really shows.Key FindingsClinical Evidence Base: Over 15 peer-reviewed studies involving 1,000+ patients support the therapy2023 Meta-Analysis: Almsaoud et al. pooled 12 studies and confirmed a weighted mean length gain of 1.9 centimetersRandomized Trial Data: Toussi et al. (2021) found 1.6 cm gain in the traction group versus 0.3 cm in controls, statistically significantCalibrated Tension Range: 900 to 2,800 grams applied 4 to 6 hours daily over 3 to 6 monthsSafety Profile: No serious adverse events reported; mild temporary events at 11.2 to 14.4 percentAdherence Rate: 82 percent across clinical studies, indicating the protocol is manageableThe SciencePenile traction applies sustained calibrated mechanical force that triggers mechanotransduction, the cellular response to strain, which drives collagen remodeling within the tunica albuginea. This is the same biological principle used in orthopedic limb lengthening and tissue expansion.About SizeGeneticsFDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.ResourcesFull Guide: Penile Traction Therapy FAQClinical Studies OverviewDoes Penile Traction Therapy Work?Safety Profile and Adverse EventsTreatment Protocol GuideMedical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

Episode SummaryThis episode is a practical guide to understanding penile traction therapy studies — how to evaluate evidence, spot bias, and decide what research actually applies to you. We walk through key meta-analyses, randomized trials, and prospective studies that form the clinical foundation of traction therapy.Key Findings2023 Almsaoud Meta-Analysis: 12 studies, 1,000+ patients — 1.9 cm mean length gain, 27% curvature reduction, 82% adherence, 80% satisfactionToussi 2021 RCT: 82 post-prostatectomy men — 1.6 cm gain vs 0.3 cm control (p value of 0.01)Gontero 2009: 15 men over 6 months — 1.3 cm mean gain, no significant adverse eventsNikoobakht 2011: 1.7 cm gain in flaccid and stretched length with dose-response patternEvaluation Framework: Check patient population, funding source, study design, and verify on PubMedThe SciencePenile traction therapy applies calibrated mechanical tension that activates mechanotransduction — the cellular response to sustained force — leading to measurable tissue remodeling in the tunica albuginea when protocols are followed consistently.About SizeGeneticsFDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.ResourcesFull Guide: Understanding Penile Traction StudiesClinical Studies OverviewPenile Traction Therapy ResultsStudies DatabaseDoes Traction Therapy Work?Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

Episode SummaryWho should use penile traction therapy — and who shouldn't? This episode breaks down the three evidence-based candidate groups, key contraindications, and what the clinical literature reveals about proper patient selection for penile traction therapy.Key FindingsThree candidate groups: Chronic-phase Peyronie's disease, post-prostatectomy rehabilitation, and medically assessed length concerns2023 Meta-Analysis (Almsaoud et al.): 12 studies, 1,000+ patients, 1.9 cm mean length gain and 27% curvature improvementToussi 2021 RCT: Post-prostatectomy patients gained 1.6 cm vs. 0.3 cm in controls, with 93% recommending the therapyAdherence threshold: 4–6 hours daily for 3–6 months required for meaningful outcomesSafety profile: Adverse events 11.2–14.4%, all mild and temporary, no serious events reportedThe SciencePenile traction therapy works through mechanotransduction — the cellular response to sustained mechanical tension that triggers collagen remodeling and tissue expansion. Proper candidacy and adherence are essential to achieve the therapeutic response documented in clinical studies.About SizeGeneticsFDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.ResourcesFull Guide: Who Should Use Penile Traction TherapyPeyronie's Disease TreatmentPost-Surgical RehabilitationSafety Profile and Adverse EventsTreatment Protocol GuideMedical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

Episode SummaryPost-surgical penile rehabilitation determines whether tissue heals at preserved length or contracts permanently shorter. This episode reviews the clinical evidence behind penile traction therapy as a rehabilitation tool after radical prostatectomy, Peyronie's grafting, and penile fracture repair — including the cellular mechanism of mechanotransduction and protocol specifics by surgery type.Key FindingsToussi (2021): Traction group averaged 1.6 cm gain vs 0.3 cm in controls (p<0.01), with 87–93% satisfaction ratesJoseph et al. (2020): 94% of participants increased length when traction was combined with low-dose tadalafilAlmsaoud (2023) meta-analysis: Weighted mean gain of 1.9 cm across 1,000+ patients with 4–6 hours daily tractionDevice force range: SizeGenetics delivers 900–2,800 g of calibrated tension, independently audited by Dr. Jørn Ege SianaProstatectomy protocol: Clearance at 4–6 weeks post-op, starting at 900 g for 2 hours/day, escalating to 6–8 hours by week 12The ScienceMechanotransduction triggers micro-tears along parallel collagen bundles, prompting reorganization of fibers into uniform, densely packed fibrils aligned with the axis of mechanical strain — the same biological mechanism behind orthopedic bone lengthening and reconstructive skin expansion.About SizeGeneticsFDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.ResourcesFull Guide: Post-Surgical Penile RehabilitationPeyronie's Disease TreatmentCollagen Remodeling ScienceClinical Studies OverviewMedical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

Episode SummaryThis episode traces the history of penile traction therapy from ancient stretching practices to its 1994 transformation into a clinical discipline. Dr. Jørn Ege Siana's reconstructive surgery insight in Denmark created the first calibrated medical penile traction device — laying the foundation for over 15 peer-reviewed clinical studies.Key FindingsAncient practices: Stretching, binding, and weight-hanging documented across Africa, India, Egypt, and Nubia — but uncontrolled force led to nerve and vascular injury1994 invention: Dr. Jørn Ege Siana, plastic surgeon at Danamedic ApS in Copenhagen, applied tissue expansion principles to penile medicinePatent filed: February 1995 by Danamedic founder Jes Bech Müller, launched as Jes-Extender OriginalClinical evidence: Gontero 2009 (1.3 cm gain), Nikoobakht 2010 (1.7 cm gain), Toussi 2021 (1.6 cm preserved post-prostatectomy)Modern protocol: 4–6 hours daily over 3–6 months, with clinically validated gains of 1.3–2.3 cmScale: 1,000,000+ units sold across Danamedic brands over 30+ yearsThe ScienceMechanotransduction — the cellular response to controlled mechanical force — drives tissue expansion in penile traction therapy. The same principle is established in burn reconstruction, breast reconstruction, and limb lengthening procedures.About SizeGeneticsFDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.ResourcesFull Guide: History of Penile Traction TherapyPenile Traction Therapy OverviewHow Penile Traction Therapy WorksClinical Studies on Traction TherapyResults and Clinical OutcomesMedical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

Episode SummaryThis episode explains the medical principle of tissue expansion — the foundation of penile traction therapy. Used in reconstructive surgery since the 1950s, tissue expansion demonstrates that the body responds to controlled, sustained mechanical force by generating new tissue.Key FindingsHistorical foundation: Dr. Charles Neumann pioneered subcutaneous balloon expansion in 1957; Dr. Chedomir Radovan advanced it for breast reconstruction in 1982.Mechanotransduction: Cells convert mechanical tension into biochemical signals, triggering cell division, collagen synthesis, growth factor release, and angiogenesis.Plastic deformation and creep: Sustained therapeutic tension produces irreversible elongation, not just temporary stretch.Clinical evidence: Peer-reviewed studies show 1.3–2.3 cm gains over 3–6 months. Toussi et al. (2021) RCT reported 1.6 cm gain vs. 0.3 cm control, with 87% willing to repeat treatment.Safety record: Across 15+ peer-reviewed studies, no serious adverse events reported.The SciencePenile traction therapy applies the same mechanotransduction principle used in reconstructive medicine — calibrated, sustained tension drives cellular remodeling and permanent tissue formation through plastic deformation.About SizeGeneticsFDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.ResourcesFull Guide: Tissue Expansion and Penile Traction TherapyHow Penile Traction Therapy WorksCollagen Remodeling Under TensionClinical Studies OverviewHistory of Penile Traction TherapyMedical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

Episode SummaryOver 30 years of clinical research involving 1,000+ patients demonstrates that penile traction therapy with an FDA-registered Class II medical device has zero serious adverse events. This episode breaks down the safety data from 15+ peer-reviewed studies and explains what temporary side effects actually mean for treatment outcomes.Key FindingsZero Serious Adverse Events: 30+ years of clinical research across 1,000+ patients with no serious complications reported2023 Meta-Analysis: Almsaoud, Safar, and Alshahrani confirmed safety across 12 pooled clinical studies in Translational Andrology and UrologyMild Adverse Event Rate: 11-14% temporary effects (skin irritation within 24 hours, discomfort resolves immediately, transient numbness 30-60 minutes)Patient Satisfaction: 87% repeat rate and 93% recommendation rate in randomized controlled trialsTherapeutic Tension Range: SizeGenetics delivers 900-2,800 grams (8.8-27.5 Newtons) within evidence-established safety windowThe SciencePenile traction therapy applies controlled mechanical tension to penile tissue, stimulating collagen remodeling and cellular adaptation within the tunica albuginea and corpora cavernosa. The therapeutic tension window (900-2,800 grams) is calibrated based on three decades of clinical safety data, ensuring efficacy without tissue damage.About SizeGeneticsFDA-registered Class II medical device manufactured by Danamedic ApS in Denmark since 1994 — the company that invented penile traction therapy. Delivers calibrated tension of 900–2,800 grams within the exact therapeutic range established by clinical studies. Over 1 million units sold worldwide. Co-invented by Dr. Jørn Ege Siana, plastic surgeon and medical advisor based in Copenhagen.ResourcesFull Guide: Penile Traction Therapy SafetyPenile Traction Therapy: Clinical Evidence and MechanismClinical Studies: 15+ Peer-Reviewed ResearchTreatment Protocol: Safe Usage GuidelinesMedical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

Episode SummaryWhat results can you actually expect from penile traction therapy? In this episode, we break down 15+ peer-reviewed clinical studies involving over 1,000 patients — real measured outcomes, not marketing claims.Key FindingsAverage length gain: 1.3–2.3 cm over 3–6 months of daily use across 15+ studies2023 meta-analysis (Almsaoud et al.): 12 studies, 1,000+ patients, 1.9 cm weighted mean gainJoseph 2020 RCT: 110 participants, 94% achieved measurable length increases (1.6–2.3 cm)Toussi 2021 RCT: 82 men, traction group gained 1.6 cm vs. 0.3 cm control (p < 0.01)Safety: Zero serious adverse events reported across all major clinical trialsPatient satisfaction: 87% would repeat therapy, 93% would recommend itThe SciencePenile traction works through mechanotransduction — the cellular response to sustained mechanical force. The same biological principle used in orthopedic limb lengthening and tissue reconstruction for decades.About SizeGeneticsFDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.Resources📖 Full Guide: Results & Expected Outcomes🔬 Clinical Studies & Evidence⚙️ How Penile Traction Therapy Works🛡️ Safety & Side Effects📏 How to Measure Correctly⚕️ Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment. Click here to watch a video of this episode.